Sign In
Buy CRBP
$7.38
-0.160 (-2.12%)
At Close: Jun 03, 2026
Cannabis Central: What Crash? 20 Pot Stocks Actually Went Up Last Week
09:17am, Monday, 23'rd Mar 2020
The cannabis stock sector declined 6.25% last week with 17 of the non-penny stocks declining and 20 non-penny pot stocks actually going UP.
Cannabis Central: These 19 Pot Stocks Matched Or Exceeded The Sector's 4.7% Increase On Friday
07:06pm, Saturday, 21'st Mar 2020
The cannabis stock sector went up Friday 4.7% on the heels of a 7.5% advance Thursday with 19 of the non-penny pot stocks matching or exceeding that average increase. This article identifies those 19
Charles Schwab Investment Management Inc. Purchases 19,179 Shares of Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP)
10:10am, Saturday, 21'st Mar 2020
Charles Schwab Investment Management Inc. increased its position in shares of Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP) by 14.0% in the 4th quarter, according to the company in its most recent
Ascendis Pharma (ASND) Received its Third Buy in a Row
08:14pm, Thursday, 19'th Mar 2020
After Cantor Fitzgerald and Morgan Stanley gave Ascendis Pharma (NASDAQ: ASND) a Buy rating last month, the company received another Buy, this time from
Ascendis Pharma (ASND) Received its Third Buy in a Row
08:14pm, Thursday, 19'th Mar 2020
After Cantor Fitzgerald and Morgan Stanley gave Ascendis Pharma (NASDAQ: ASND) a Buy rating last month, the company received another
Even if it's not a huge purchase, we think it was good to see that Barbara White, the Head of Research & Chief Medical...
Better Buy: GW Pharmaceuticals vs. Corbus Pharmaceuticals
01:30pm, Wednesday, 18'th Mar 2020
These cannabinoid-based drug developers offer different risk/reward profiles.
Will COVID-19 Derail New Drugs?
11:30am, Wednesday, 18'th Mar 2020
Disruptions in clinical trials and delayed regulatory decisions could slow the rate of new drug approvals.
Oppenheimer Keeps Their Buy Rating on Catalyst Pharma (CPRX)
09:50am, Wednesday, 18'th Mar 2020
Oppenheimer analyst Leland Gershell maintained a Buy rating on Catalyst Pharma (CPRX) today and set a price target of $10.00. The company's shares closed
Oppenheimer Keeps Their Buy Rating on Catalyst Pharma (CPRX)
09:50am, Wednesday, 18'th Mar 2020
Oppenheimer analyst Leland Gershell maintained a Buy rating on Catalyst Pharma (CPRX – Research Report) today and set a price
Cannabis Central: Befitting St. Patrick's Day Sector Saw Much More Green Today
09:17am, Wednesday, 18'th Mar 2020
Befitting St. Patrick's Day, the cannabis sector's performance turned much more green on Tuesday remaining virtually unchanged.
Corbus Pharmaceuticals Holdings, Inc. Just Reported Earnings, And Analysts Cut Their Target Price
12:52pm, Saturday, 14'th Mar 2020
There's been a notable change in appetite for Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) shares in the week...
Corbus Pharmaceuticals Holdings, Inc. Just Reported Earnings, And Analysts Cut Their Target Price
12:50pm, Saturday, 14'th Mar 2020
There's been a notable change in appetite for Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) shares in the week...
Corbus Pharmaceuticals (CRBP) Gets a Buy Rating from H.C. Wainwright
11:12am, Friday, 13'th Mar 2020
In a report released today, Andrew Fein from H.C. Wainwright reiterated a Buy rating on Corbus Pharmaceuticals (CRBP), with a price target of $24.00. The
Corbus Pharmaceuticals (CRBP) Gets a Buy Rating from H.C. Wainwright
11:12am, Friday, 13'th Mar 2020
In a report released today, Andrew Fein from H.C. Wainwright reiterated a Buy rating on Corbus Pharmaceuticals (CRBP – Research
